BRUSSELS, June 6 (Reuters) - Belgian health products distributor Omega Pharma (OMEP.BR: Quote, Profile, Research) said on Tuesday it expected to spin off its business-to-business unit, which it renamed Arseus, through a separate stock market listing in 2008.
